Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT2206 vs Stelara in moderate-to-severe plaque psoriasis
CTR20211401Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Jun 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of BAT2206 in plaque psoriasis, sponsored by Bio-Thera Solutions, Ltd.. Started Jun 2021; status: completed.
02
Drugs
BAT2206
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on CTR20211401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211401.